RAPAd®

The RAPAd® method of Adenovirus construction, developed by ViraQuest Inc. scientists, has been used by other scientists around the world.

Request Quote

Confidentiality

 

Learn More

Quality Control

Plaque forming units guarantee. Non-detectable RCA.

Learn More

Turnaround Time

Sub-cloning to finished particles in about four weeks.

Learn More

Dual Expressers

Multiple transgene expression in a single virus.

Learn More

Yearly Archives: 2011

Functional characterization of mutations in inherited human cPLA? deficiency.

Authors: Reed KA, Tucker DE, Aloulou A, Adler D, Ghomashchi F, Gelb MH, Leslie CC, Oates JA, Boutaud O.
Citation: Biochemistry. 2011 Mar 15;50(10):1731-8.

read more

Induction and comparison of SIV immunity in Ad5 na

Authors: Gabitzsch ES, Xu Y, Balint JP Jr, Balcaitis S, Sanders-Beer B, Jones FR.
Citation: Vaccine. 2011 Oct 19;29(45):8101-7.

read more

An Ad5[E1-, E2b-]-HER2/neu vector induces immune responses and inhibits HER2/neu expressing tumor progression in Ad5 immune mice.

Authors: Gabitzsch ES, Xu Y, Balcaitis S, Balint JP Jr, Jones FR.
Citation: Cancer Gene Ther. 2011 May;18(5):326-35.

read more

MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.

Authors: de Antonellis P, Medaglia C, Cusanelli E, Andolfo I, Liguori L, De Vita G, Carotenuto M, Bello A, Formiggini F, Galeone A, De Rosa G, Virgilio A, Scognamiglio I, Sciro M, Basso G, Schulte JH, Cinalli G, Iolascon A, Zollo M.
Citation: PLoS One. 2011;6(9):e24584.

read more

Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo.

Authors: Harvey TJ, Hennig IM, Shnyder SD, Cooper PA, Ingram N, Hall GD, Selby PJ, Chester JD.
Citation: Cancer Gene Ther. 2011 Nov;18(11):773-84. doi: 10.1038/cgt.2011.43.

read more

Re-expression of the methylated EDNRB gene in oral squamous cell carcinoma attenuates cancer-induced pain.

Authors: Viet CT, Ye Y, Dang D, Lam DK, Achdjian S, Zhang J, Schmidt BL.
Citation: Pain. 2011 Oct;152(10):2323-32.

read more

Distinct Redox Profiles of Selected Human Prostate Carcinoma Cell Lines: Implications for Rational Design of Redox Therapy

Authors: Luksana Chaiswing, , Weixiong Zhong, and Terry D. Oberley
Citation: Cancers 2011, 3(3), 3557-3584

read more

Divergent activities of osteogenic BMP2, and tenogenic BMP12 and BMP13 independent of receptor binding affinities.

Authors: Berasi SP, Varadarajan U, Archambault J, Cain M, Souza TA, Abouzeid A, Li J, Brown CT, Dorner AJ, Seeherman HJ, Jelinsky SA.
Citation: Growth Factors. 2011 Aug;29(4):128-39.

read more

WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity.

Authors: Ono M, Inkson CA, Kilts TM, Young MF.
Citation: J Bone Miner Res. 2011 Jan;26(1):193-208.

read more